Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

12 Best Marijuana Stocks To Invest In

In this article, we discuss 12 best marijuana stocks to invest in. If you want to skip our discussion on the cannabis market, head over to 5 Best Marijuana Stocks To Invest In

In 2024, the global cannabis market is poised for substantial growth due to emerging legal markets, innovative products, and technological advancements. The US cannabis market is expected to significantly expand, with projected retail sales reaching $53.5 billion by 2027, driven by the growth in adult-use cannabis. States like New York are contributing to this growth by finalizing details for approved cannabis programs. The trend towards personalized cannabis products is expected to rise as consumers become more educated, leading companies to tailor products to individual needs. While pre-rolls are projected to remain popular, there is a growing expectation that consumers will increasingly favor craft cannabis products and artisanal flower, despite the enduring demand for low-cost and convenient options.

In 2024, the National Cannabis Industry Association predicts the legalization of recreational cannabis in several additional states, but federal legalization remains uncertain, evidenced by the challenges facing the SAFER Banking Act in Congress. The SAFE Banking Act continues to be a significant issue, with potential developments expected in 2024. Potential actions by President Biden may reshape the industry’s regulatory framework, impacting financial reporting and taxation. States such as Maryland, and potentially Pennsylvania and Ohio, could influence regional market dynamics and tax structures. In  November 2023, CNBC quoted Jaret Seiberg, a policy analyst at TD Cowen, who commented: 

“Legalization of cannabis is inevitable. It’s just a question of how bumpy the next several years are going to be.”

Marijuana-related ETFs experienced a significant surge in September 2023, as investors re-entered the sector following months of declining interest. This upswing was notably substantial, attributed to the U.S. Department of Health and Human Services’ recommendation to ease restrictions on marijuana after a review of its classification under the Controlled Substances Act. The industry, previously constrained by slow federal reform, faced slow growth and losses in recent quarters. Despite marijuana legalization in 39 states, challenges persist due to the Schedule I classification and federal prohibition, limiting access to financing and broader market opportunities. Following the HHS recommendation, Canaccord Genuity analyst Matt Bottomley commented: 

“This is effectively a continuation of what’s the most material element in how these stocks trade, which are federal catalysts. Velocity is so much higher on these federal headlines.”

On December 26, Boris Jordan, Executive Chairman of CuraLeaf, participated in CNBC’s ‘Fast Money’ to discuss the outlook for the cannabis sector in 2024. Jordan stated that ‘anything will be better than 2023, it was a terrible year’. He listed drivers that impacted the cannabis industry in 2023, including slower growth, higher cost of capital, and regulatory impediments. He said that the regulatory framework is better for 2024, with New York getting on board with adult-use cannabis programs. Florida is also expected to approve adult-use cannabis next year, according to Jordan. In 2024, Jordan observed that the industry’s direction depends on the US Federal Government, whether it moves cannabis from the Schedule 1 to Schedule 3 list, which would free up substantial cash in the sector. He added that currently, the marijuana businesses pay around 70% tax rate, which would then drop to a normal tax rate if the substance is categorized as Schedule 3. This would create a positive business dynamic in the industry and result in growth. 

Some of the best marijuana stocks to invest in include The Scotts Miracle-Gro Company (NYSE:SMG), Tilray Brands, Inc. (NASDAQ:TLRY), and Innovative Industrial Properties, Inc. (NYSE:IIPR). 

Our Methodology 

We chose the top marijuana stocks based on overall hedge fund sentiment toward each stock. We have assessed the hedge fund sentiment from Insider Monkey’s database of 933 elite hedge funds tracked as of the end of the fourth quarter of 2023. The list is arranged in ascending order of the number of hedge fund holders in each firm. Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here). 

Pixabay/Public domain

Best Marijuana Stocks To Invest In

12. Organigram Holdings Inc. (NASDAQ:OGI)

Number of Hedge Fund Holders: 3

Organigram Holdings Inc. (NASDAQ:OGI) is focused on the production and sale of cannabis and cannabis-derived products in Canada. Their product offerings include medical cannabis products such as whole flower, milled flower, pre-rolls, vapes, gummies, and concentrates for medical retailers, as well as adult-use recreational cannabis. Organigram Holdings Inc. (NASDAQ:OGI) reported its revenue for the first fiscal quarter of 2024, which came in at C$36.5 million. As of December 31, 2023, the company had a total cash position of C$54.6 million, consisting of C$41.8 million in unrestricted cash and C$12.8 million in restricted cash.

According to Insider Monkey’s fourth quarter database, 3 hedge funds were bullish on Organigram Holdings Inc. (NASDAQ:OGI), compared to 4 funds in the prior quarter. D E Shaw is the largest stakeholder of the company, with 146,500 shares worth $190,116. 

Like The Scotts Miracle-Gro Company (NYSE:SMG), Tilray Brands, Inc. (NASDAQ:TLRY), and Innovative Industrial Properties, Inc. (NYSE:IIPR), Organigram Holdings Inc. (NASDAQ:OGI) is one of the best marijuana stocks to invest in. 

11. Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)

Number of Hedge Fund Holders: 5

Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) ranks 11th on our list of the best marijuana stocks. The company is involved in the manufacturing and distribution of controlled environment agriculture equipment and supplies in the United States and Canada. Their product range includes agricultural lighting devices, indoor climate control equipment, nutrients, and plant additives for growing cannabis, flowers, fruits, vegetables, grains, and herbs in controlled environments. Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM)’s Q3 2023 Q3 GAAP EPS came in at -$0.44 and its revenue was $54.2 million. Net sales for full-year 2023 were expected to range between $230 million and $240 million.

According to Insider Monkey’s fourth quarter database, 5 hedge funds were bullish on Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM), compared to 6 funds in the earlier quarter. Michael Zimmerman’s Prentice Capital Management is the largest stakeholder of the company, with 464,108 shares worth $425,819. 

Here is what Baron Discovery Fund has to say about Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) in its Q4 2021 investor letter:

“Our top 10 holdings represented 25.6% of the Fund’s net assets at the end of the fourth quarter. This is in line with historical weightings. Cash at the end of the quarter was 3.4%, which is in line with our low to mid-single digit targeted levels. We exited our position in Hydrofarm Holdings Group, Inc. as we felt the macro headwinds the company was facing in its end-markets were both challenging and worsening.”

10. Village Farms International, Inc. (NASDAQ:VFF)

Number of Hedge Fund Holders: 6

Village Farms International, Inc. (NASDAQ:VFF) specializes in the production, marketing, and sale of greenhouse-grown tomatoes, bell peppers, and cucumbers in North America. The company operates through four segments – Produce, Cannabis-Canada, Cannabis-U.S., and Energy. Village Farms International, Inc. (NASDAQ:VFF) also produces and supplies cannabis products to licensed providers and provincial governments worldwide. It is one of the best marijuana stocks to watch. 

On January 31, Village Farms International, Inc. (NASDAQ:VFF) announced that it is building its first indoor cannabis production facility in the Netherlands through its subsidiary, Leli Holland. The company, holding a license for legal recreational cannabis production in the Netherlands, aims to start production in Q4 2024. Leli Holland plans to sell different cannabis products, and the construction will be funded using Village Farms’ existing cash reserves.

According to Insider Monkey’s fourth quarter database, 6 hedge funds were bullish on Village Farms International, Inc. (NASDAQ:VFF), compared to 4 funds in the last quarter. Israel Englander’s Millennium Management is a prominent stakeholder of the company, with 124,673 shares worth $95 million. 

9. Aurora Cannabis Inc. (NASDAQ:ACB)

Number of Hedge Fund Holders: 6

Aurora Cannabis Inc. (NASDAQ:ACB) is involved in the production, distribution, and sale of cannabis and cannabis-derived products globally. The company operates through three segments – Canadian Cannabis, European Cannabis, and Plant Propagation. On February 9, Canaccord Genuity upgraded its rating on Aurora Cannabis Inc. (NASDAQ:ACB) to Buy, citing a favorable valuation. Despite the expected performance in Q3 and a 25% decrease in Aurora Cannabis Inc. (NASDAQ:ACB) shares since Q2 2023, the analysts noted moderate progress towards sustainable profitability as a factor in the upgrade. Aurora Cannabis Inc. (NASDAQ:ACB) is one of the best marijuana stocks to monitor. 

According to Insider Monkey’s fourth quarter database, 6 hedge funds were bullish on Aurora Cannabis Inc. (NASDAQ:ACB), compared to 7 funds in the prior quarter. Israel Englander’s Millennium Management is a prominent stakeholder of the company, with 31,654 shares valued at $154,466. 

8. Cronos Group Inc. (NASDAQ:CRON)

Number of Hedge Fund Holders: 7

Cronos Group Inc. (NASDAQ:CRON) is a cannabinoid company based in Toronto, Canada. Cronos Group Inc. (NASDAQ:CRON) is engaged in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for both medical and adult-use markets. It is one of the best marijuana stocks to invest in. On November 8, 2023, Cronos Group Inc. (NASDAQ:CRON) reported a Q3 GAAP EPS of $0.00 and a revenue of $24.81 million, exceeding Wall Street estimates by $0.03 and $5.24 million, respectively. Revenue for the third quarter increased 21.6% on a year-over-year basis. 

According to Insider Monkey’s fourth quarter database, 7 hedge funds were bullish on Cronos Group Inc. (NASDAQ:CRON), compared to 8 funds in the prior quarter. Traci Lerner’s Chescapmanager LLC is the leading stakeholder of the company, with 8.3 million shares worth $17.40 million. 

7. GrowGeneration Corp. (NASDAQ:GRWG)

Number of Hedge Fund Holders: 8

GrowGeneration Corp. (NASDAQ:GRWG) owns and operates retail hydroponic and organic gardening stores across the United States. The company specializes in the marketing and distribution of products for hydroponic gardening, including nutrients, growing media, lighting, environmental control systems, vertical benching, and accessories. GrowGeneration Corp. (NASDAQ:GRWG) is one of the best marijuana stocks to buy. 

On January 8, GrowGeneration Corp. (NASDAQ:GRWG) announced that it anticipates full-year 2023 revenue to reach the upper limit of the previously provided guidance range of $220 million to $225 million. The adjusted EBITDA guidance for FY23 remains unaltered, with a projected loss between $4 million to $6 million.

According to Insider Monkey’s fourth quarter database, 8 hedge funds were bullish on GrowGeneration Corp. (NASDAQ:GRWG), compared to 7 funds in the last quarter. D E Shaw is the leading stakeholder of the company, with 772,855 shares valued at approximately $2 million. 

6. WM Technology, Inc. (NASDAQ:MAPS)

Number of Hedge Fund Holders: 11

WM Technology, Inc. (NASDAQ:MAPS) offers e-commerce and compliance software solutions to retailers and brands in the cannabis market, operating in the United States and internationally. Their Weedmaps marketplace enables cannabis users to search for and browse products, reserve items from local retailers, and provides educational information. On November 8, 2023, WM Technology, Inc. (NASDAQ:MAPS) reported a Q3 GAAP EPS of -$0.02, in-line with market consensus. Revenue for the quarter came in at $47.73 million, outperforming Wall Street estimates by $0.39 million. 

According to Insider Monkey’s fourth quarter database, 11 hedge funds were long WM Technology, Inc. (NASDAQ:MAPS), compared to 9 funds in the last quarter. Falcon Edge Capital is the largest stakeholder of the company, with 2.12 million shares worth $1.5 million. 

In addition to The Scotts Miracle-Gro Company (NYSE:SMG), Tilray Brands, Inc. (NASDAQ:TLRY), and Innovative Industrial Properties, Inc. (NYSE:IIPR), WM Technology, Inc. (NASDAQ:MAPS) is one of the best marijuana stocks to consider. It ranks 6th on our list. 

Click to continue reading and see 5 Best Marijuana Stocks To Invest In

Suggested articles:

Disclosure: None. 12 Best Marijuana Stocks To Invest In is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

 

Wall Street calls this $3 stock a “Melting Ice Cube.” They said the same thing about BTI before it returned 90%.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.